Antisense Oligonucleotides Targeting an LDLR Regulatory RNA Increase LDLR Expression and Reduce LDL-cholesterol in Vivo
Preprint
Abstract
Regulatory RNAs (regRNAs) are non-coding RNAs expressed from promoters and enhancers that modulate gene transcription. Targeting regRNAs with antisense oligonucleotides (ASOs) can increase transcription and presents a potential therapeutic strategy to restore expression in haploinsufficient diseases. This approach requires high-quality regRNA maps, identification of ASOs targeting actionable sequences, and translation of efficacy to relevant animal models. Here, we describe this approach for human low-density lipoprotein receptor ( LDLR ). We characterized LDLR regRNAs in HepG2 cells and human liver using epigenomic mapping and regRNA Capture-seq, and designed ASOs targeting these regRNAs. Several ASOs increased LDLR expression in cells and a lead was evaluated for efficacy in a humanized liver mouse model. ASO administration increased human LDLR mRNA and protein, while lowering LDL-cholesterol in plasma. These data provide a framework for the discovery and translation of ASOs that increase gene expression as a potential therapeutic approach for the treatment of haploinsufficient diseases.Keywords
This publication has 37 references indexed in Scilit:
- CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for AtherosclerosisJournal of Cardiovascular Translational Research, 2025
- An RNA-centric view of transcription and genome organizationMolecular Cell, 2024
- PRO‐seq: Precise Mapping of Engaged RNA Pol II at Single‐Nucleotide ResolutionCurrent Protocols, 2023
- Transcription factors interact with RNA to regulate genesMolecular Cell, 2023
- Existing and emerging therapies for the treatment of familial hypercholesterolemiaJournal of Lipid Research, 2021
- RNA-Mediated Feedback Control of Transcriptional CondensatesCell, 2020
- Control of LDL Uptake in Human Cells by Targeting the LDLR Regulatory Long Non-coding RNA BM450697Molecular Therapy Nucleic Acids, 2019
- Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet SyndromeEBioMedicine, 2016
- ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐WideCurrent Protocols in Molecular Biology, 2015
- Activation of LDL Receptor Expression by Small RNAs Complementary to a Noncoding Transcript that Overlaps the LDLR PromoterChemistry & Biology, 2010